Events & Presentations

Title: PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF PLOZASIRAN IN SUBJECTS WITH RENAL OR HEPATIC IMPAIRMENT
Session: Late Breaker Clinical Abstracts
Date/Time: May 26, 2026, 5:00 AM – 5:15 PM
Presenter: Jennifer Hellawell, MD

Title: A CASE REPORT OF A PREGNANT WOMAN WITH FAMILIAL CHYLOMICRONEMIA SYNDROME TREATED WITH PLOZASIRAN, A SMALL INTERFERING RNA AGAINST APOC3
Session: EAS stage: Outreach and case presentations
Date/Time: May 26, 2026, 8:30 AM – 10:30 AM
Presenter: Ann Mertens, MD

Title: Systemic RNAi Targeting MAPT: Advancing Tau Suppression Across the CNS with TRiM™ SC 
Date/Time: May 13, 2026, 4:45 PM EDT 
Presenter: Kayal Madhivanan

 

Title: Elevated Activin E levels correlate with insulin resistance and metabolic dysfunction in non-human primates and adult patients with obesity and type 2 diabetes 
Date/Time: May 13-14;  1:00 PM – 3:00 PM 
Presenter: Jane Kerr, MBChB, MPH, DRCOG